Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Influence of risperidone on balance control in young healthy individuals.

Corbeil P, Rodrigue J, Simoneau M, Cohen H, Pourcher E.

Psychopharmacology (Berl). 2012 Jul;222(1):59-69. doi: 10.1007/s00213-011-2623-7. Epub 2012 Jan 11.

PMID:
22234381
2.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
3.

Extrapyramidal symptoms in patients treated with risperidone.

Simpson GM, Lindenmayer JP.

J Clin Psychopharmacol. 1997 Jun;17(3):194-201.

PMID:
9169965
4.
5.

A qualitative assessment of the neurological safety of antipsychotic drugs; an analysis of a risperidone database.

Fleischhacker WW, Lemmens P, van Baelen B.

Pharmacopsychiatry. 2001 May;34(3):104-10.

PMID:
11434401
6.

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.

Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M.

J Clin Psychiatry. 1999 Feb;60(2):107-15.

PMID:
10084637
7.

Risperidone plasma levels, clinical response and side-effects.

Riedel M, Schwarz MJ, Strassnig M, Spellmann I, Müller-Arends A, Weber K, Zach J, Müller N, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2005 Aug;255(4):261-8. Epub 2004 Nov 29.

PMID:
15565299
8.

Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic.

Fleischhacker WW, Eerdekens M, Karcher K, Remington G, Llorca PM, Chrzanowski W, Martin S, Gefvert O.

J Clin Psychiatry. 2003 Oct;64(10):1250-7.

PMID:
14658976
9.

Effect of risperidone on behavioral and psychological symptoms and cognitive function in dementia.

Rainer MK, Masching AJ, Ertl MG, Kraxberger E, Haushofer M.

J Clin Psychiatry. 2001 Nov;62(11):894-900.

PMID:
11775050
10.

A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.

Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, Lee E, Lyons B, Grossman F.

J Clin Psychiatry. 2003 Feb;64(2):134-43.

PMID:
12633121
11.

Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers.

Allain H, Tessier C, Bentué-Ferrer D, Tarral A, Le Breton S, Gandon M, Bouhours P.

Psychopharmacology (Berl). 2003 Feb;165(4):419-29. Epub 2002 Nov 30.

PMID:
12459926
13.

The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics.

Miller CH, Mohr F, Umbricht D, Woerner M, Fleischhacker WW, Lieberman JA.

J Clin Psychiatry. 1998 Feb;59(2):69-75.

PMID:
9501888
14.

Oral risperidone plus oral lorazepam versus standard care with intramuscular conventional neuroleptics in the initial phase of treating individuals with acute psychosis.

Lejeune J, Larmo I, Chrzanowski W, Witte R, Karavatos A, Schreiner A, Lex A, Medori R.

Int Clin Psychopharmacol. 2004 Sep;19(5):259-69.

PMID:
15289699
16.

Thioridazine dose-related effects on biomechanical force platform measures of sway in young and old men.

Liu YJ, Stagni G, Walden JG, Shepherd AM, Lichtenstein MJ.

J Am Geriatr Soc. 1998 Apr;46(4):431-7.

PMID:
9560064
17.

Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.

Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Jockers-Scherübl MC, Kühn KU, Lemke M, Bechdolf A, Bender S, Degner D, Schlösser R, Schmidt LG, Schmitt A, Jäger M, Buchkremer G, Falkai P, Klingberg S, Köpcke W, Maier W, Häfner H, Ohmann C, Salize HJ, Schneider F, Möller HJ; German Study Group on First-Episode Schizophrenia.

J Clin Psychiatry. 2007 Nov;68(11):1763-74.

PMID:
18052570
18.
19.

Secondary nonmotor negative symptoms in healthy volunteers after single doses of haloperidol and risperidone: a double-blind, crossover, placebo-controlled trial.

Mas S, Gassó P, Fernández de Bobadilla R, Arnaiz JA, Bernardo M, Lafuente A.

Hum Psychopharmacol. 2013 Nov;28(6):586-93. doi: 10.1002/hup.2350. Epub 2013 Oct 7.

PMID:
24519692
20.

A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities.

Buitelaar JK, van der Gaag RJ, Cohen-Kettenis P, Melman CT.

J Clin Psychiatry. 2001 Apr;62(4):239-48.

PMID:
11379837

Supplemental Content

Support Center